What is the likely cause and recommended management for a rash with hives and peri‑oral skin peeling that develops four days after starting Augmentin (amoxicillin/clavulanate)?

Immediate Management: Discontinue Augmentin and Document Penicillin Allergy

Stop Augmentin immediately—this is a delayed hypersensitivity reaction (Type IV) to amoxicillin/clavulanate, presenting as a morbilliform rash with urticaria and peri-oral skin peeling occurring 4 days after initiation. This timing and presentation are classic for delayed penicillin reactions 1.

Clinical Assessment and Severity Stratification

Rule Out Severe Cutaneous Adverse Reactions (SCARs)

Examine for:

• Mucosal involvement (oral, ocular, genital)—suggests Stevens-Johnson syndrome/TEN
• Facial edema, fever >38.5°C, lymphadenopathy—consider DRESS syndrome 2
• Pustular lesions—suggests AGEP
• Bullae or skin detachment—immediate dermatology consultation required

If any of these features are present, hospitalize immediately and initiate systemic corticosteroids (0.5-2 mg/kg/day prednisone equivalent) 1.

For Uncomplicated Morbilliform Rash with Urticaria

This represents the most common presentation—a benign delayed hypersensitivity reaction 3. The peri-oral peeling suggests localized contact dermatitis component, possibly from oral suspension formulation 1.

Immediate Treatment Protocol

Symptomatic management:

• Oral antihistamines: H1-blockers (cetirizine 10 mg daily or diphenhydramine 25-50 mg every 6 hours)
• Topical corticosteroids: Medium-potency (triamcinolone 0.1%) for affected areas, including peri-oral region
• Emollients: For skin barrier restoration

Monitor for 7 days post-discontinuation as delayed reactions can evolve or worsen even after stopping the drug 4. The rash typically resolves within 7-14 days after discontinuation 1.

Documentation and Future Management

Label as Penicillin Allergy

Document this reaction in the medical record as "amoxicillin/clavulanate-induced delayed hypersensitivity reaction with morbilliform rash and urticaria" 1.

Avoid All Penicillins Acutely

Do not prescribe any penicillin-class antibiotics during this acute phase. If antibiotics are still needed for the original infection:

• Respiratory infections: Macrolides (azithromycin) or respiratory fluoroquinolones
• Skin infections: Cephalexin (if no severe reaction features) or clindamycin
• UTIs: Fluoroquinolones or trimethoprim-sulfamethoxazole

Long-Term Allergy Evaluation Strategy

Most patients with delayed morbilliform rashes can be safely delabeled through formal allergy evaluation, as these reactions are often non-IgE-mediated and transient 4.

Timing of Evaluation

Wait 4-6 weeks minimum after complete rash resolution before considering allergy testing 4. This allows for resolution of the immune response.

Testing Approach

The 2022 Drug Allergy Practice Parameter recommends 4:

1. Skin testing (prick and intradermal) with:

   • Penicilloyl-polylysine (major determinant)
   • Minor determinant mixture
   • Amoxicillin/clavulanate at non-irritating concentrations

2. If skin tests are negative: Proceed to single-day oral challenge with amoxicillin or amoxicillin/clavulanate

   • Single-day challenges detect the majority of delayed reactions 4
   • Extended 3-10 day challenges are not recommended as they unnecessarily expose patients to antibiotics with minimal additional diagnostic yield 4

3. If challenge is negative: Patient can be delabeled and use penicillins safely in the future

Important Caveats

Do not pursue delabeling if:

• Severe features were present (mucosal involvement, blistering, systemic symptoms)
• Patient has history of multiple drug allergies
• Patient has no clinical need for penicillins

Resensitization is rare (<2%) after oral penicillin courses, so repeat testing is not needed unless a subsequent reaction occurs 4.

Special Consideration: EBV Co-infection

If the patient has concurrent symptoms of infectious mononucleosis (fever, pharyngitis, lymphadenopathy, fatigue), consider EBV serology 5, 6. Amoxicillin causes rash in 70-100% of patients with active EBV infection—this is not a true allergy and these patients can typically use penicillins safely once EBV resolves. However, this distinction requires serological confirmation and should not delay immediate discontinuation of Augmentin.

Key Clinical Pitfall

The most common error is permanent penicillin allergy labeling without subsequent evaluation. This leads to unnecessary use of broad-spectrum antibiotics (fluoroquinolones, carbapenems), increased healthcare costs, and worse outcomes 4. Most patients with delayed morbilliform rashes can safely use penicillins after appropriate evaluation and delabeling 4, 7.